Amplia Therapeutics Limited
INNMF
$0.12
-$0.005-4.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.24% | -11.36% | -155.02% | -145.81% | 2.52% |
| Total Depreciation and Amortization | -6.34% | -2.13% | 2.84% | 0.00% | -6.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -154.92% | -157.57% | 166.58% | 164.19% | 830.03% |
| Change in Net Operating Assets | 36.00% | 32.92% | -- | -- | -214.38% |
| Cash from Operations | -243.97% | -260.57% | 66.14% | 67.35% | 35.22% |
| Capital Expenditure | 28.57% | 28.57% | -- | -- | 46.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 28.57% | 28.57% | -- | -- | 46.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.05% | 98.05% | -3,689.45% | -3,689.45% | -5,415.98% |
| Issuance of Common Stock | 6,506,300.00% | 6,506,300.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6,955.56% | -6,955.56% | -762.45% | -762.45% | 54.14% |
| Cash from Financing | 1,759.16% | 1,838.88% | 2,929.64% | 2,824.48% | -841.67% |
| Foreign Exchange rate Adjustments | 2,166.67% | 2,255.56% | -168.82% | -166.32% | -35.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 364.77% | 377.52% | 133.34% | 132.14% | 9.82% |